Alector, Inc. (ALEC) vs Altimmune, Inc. (ALT)
- Alector, Inc. ALEC 2.47 −6.08%
- Altimmune, Inc. ALT 1.63 −15.54%
Alector, Inc. and Altimmune, Inc. are both Biotechnology companies. Alector, Inc. and Altimmune, Inc. are of similar size ($391.6M and $375.4M). Altimmune, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 7.0×. Alector, Inc. grew revenue faster over the last twelve months: 151.2% against 130.0%. Alector, Inc. has the higher net margin (23.9% vs 0.00%) and the higher return on invested capital (0.00% vs −34.3%). Across the 17 metrics below, Alector, Inc. leads on 12 and Altimmune, Inc. on 5.
Valuation
Profitability
| Metric | ALEC | ALT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.27% |
| Operating margin | 20.16% | 0.00% | 0.00% |
| Net margin | 23.87% | 0.00% | 0.00% |
| Free cash flow margin | (86.31%) | 0.00% | 0.00% |
| Return on equity | 47.52% | (28.87%) | (50.82%) |
| Return on assets | 16.53% | (25.58%) | (46.08%) |
| Return on invested capital | 0.00% | (34.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack